BI 765128

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 765128, covering 2024-08-27 to 2024-08-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment [Phase 1, Phase 2]

See pricing